Track Castle Biosciences's goodwill ($0) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), CSTL shows a goodwill of $0. That compares with $11M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CSTL's goodwill is now $0 (was $11M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Castle Biosciences is outperforming or lagging.
Tracking CSTL's goodwill over time shows whether Castle Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $11M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this goodwill page, Stockcircle has Castle Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.
Castle Biosciences's goodwill is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.